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EGF Regulation of PITP Dynamics Is Blocked
by Inhibitors of Phospholipase C and
of the Ras-MAP Kinase Pathway
established by using FLIM [4–6]. This technique allows
the in vivo detection of FRET, in which energy is directly
transferred from an excited donor fluorophore to a
nearby (7 nm) spectrally overlapping acceptor fluoro-
phore [7, 8]. In this study, we have used EGFP (donor)
Banafshe´ Larijani,1,3 Victoria Allen-Baume,2,3
Clive P. Morgan,2 Michelle Li,2
and Shamshad Cockcroft2,*
1Cell Biophysics Laboratory
London Research Institute
Cancer Research UK fused to PITP isoforms at the N terminus [9] and PC or
PI labeled with a fluorescent BODIPY moiety (acceptor)Lincoln’s Inn Fields Laboratory
44 Lincoln’s Inn Fields on the sn-2 acyl chain.
COS-7 cells were transfected with EGFP-PITP andLondon WC2A 3PX
2 Lipid Signalling Group EGFP-PITP, and examination by confocal microscopy
reveals that EGFP-PITP is mainly cytoplasmic and nu-Department of Physiology
University College London clear and that PITP is in the Golgi, cytoplasm, and
nucleus (see Figure S1 in the Supplementary MaterialRockefeller Building
21 University Street available with this article online). This localization is
broadly similar to that reported previously [10–12], ex-London WC1E 6JJ
United Kingdom cept that EGFP-PITP was found in the nucleus. The
COS-7 cells were incubated with 40 M BODIPY-PC or
BODIPY-PI liposomes and were examined by confocal
microscopy to ensure that the cells were labeled (FigureSummary
S1). The EGFP lifetimes of cells transfected with PITP/
were then monitored (Figures 1 and 2). The EGFP lifetimePhosphatidylinositol transfer proteins (PITP) function
in signal transduction and in membrane traffic [1, 2]. of unstimulated cells transfected with PITPwas similar
at the cytoplasm and at the plasma membrane, and itStudies aimed at elucidating the mechanism of action
of PITP have yielded a singular theme; the activity of remained unchanged in the presence of BODIPY-PC or
BODIPY-PI (Figure 1). In EGF-stimulated cells, withoutPITP stems from its ability to transfer phosphatidylino-
sitol (PI) from its site of synthesis to sites of cellular BODIPY lipids, the lifetime of EGFP remains unchanged
(data not shown). However, when the BODIPY-PC-con-activity and to stimulate the local synthesis of phos-
phorylated forms of PI. The participation of various taining cells are stimulated with EGF, a shortening of
the EGFP-PITP lifetime is observed at the plasmaphosphoinositides in EGF signal transduction and in
the trafficking of the EGF receptors is well docu- membrane (from 2.11 to 1.75 ns). When parallel experi-
ments were performed with BODIPY-PI, a significantmented [3]. Using fluorescence lifetime imaging mi-
croscopy (FLIM) to measure fluorescence resonance decrease in the EGFP-PITP lifetime to 1.60 ns was
detected in the presence of EGF. In addition, FRET isenergy transfer (FRET) between EGFP-PITP proteins
and fluorescently labeled phospholipids, we report also seen between EGFP-PITP and BODIPY-PI in the
cytoplasm (representing both the cytosol and internalthat PITP and PITP can dynamically interact with
PI or PC at the plasma membrane when stimulated membrane compartments). The corresponding FRET ef-
ficiency maps illustrate an increase to 30% at the plasmawith EGF. Additionally, PITP is localized at the Golgi,
and EGF stimulation resulted in enhanced FRET. Inhib- membrane, indicating a closer proximity of the donor
and acceptor fluorophores. This series of panels areitors of the PLC and the Ras/MAP kinase pathway were
both able to inhibit the EGF-stimulated interaction of examples of 1 of 21 cells examined, and the cumulative
data are shown in Figure 3A. These images of individualPITPwith PI at the plasma membrane. The mobility of
PITP proteins was determined by using fluorescence cells illustrate the localized change in the EGFP lifetime,
which is not apparent in the cumulative data (averagedrecovery after photobleaching (FRAP), and EGF stimu-
lation reduced the mobility at the plasma membrane. data of the entire cell).
PITP can specifically bind and transfer PI or PC, butWe conclude that the dynamic behavior of PITP and
not PE (phosphatidylethanolamine) [11]. To confirm thatPITP in vivo is a regulated process involving multiple
the specific interaction of EGFP-PITP with BODIPY-mechanisms.
PC and BODIPY-PI is due to the proximity of EGFP to
the lipid tail of the bound lipid in the binding pocket [13]Results and Discussion
and not simply the membrane [14], parallel experiments
were performed with BODIPY-PE. The labeling of theWe have examined the binding of PI or PC to PITP in
cells with BODIPY-PE was similar to that of BODIPY-PIintact cells by using FRET between EGFP-labeled PITPs
and BODIPY-PC (Figure S1). No changes in EGFP-PITPand BODIPY-labeled lipids. We have monitored FRET
lifetimes were detected when BODIPY-PE was usedby FLIM; an increase in FRET results in a decrease in
(data not shown).the fluorescence lifetime of EGFP. Specific interactions
We next investigated a PITP-truncated mutant,between proteins and lipids in vivo have already been
PITP5, lacking five amino acids from the C terminus
that has increased affinity for membranes without affect-*Correspondence: s.cockcroft@ucl.ac.uk
3 These authors contributed equally to this work. ing its lipid binding properties [15–18]. In vitro PITP5
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Figure 1. EGF-Stimulated Interaction of EGFP-PITP with BODIPY-PC and BODIPY-PI Monitored by Fluorescence Lifetime Imaging in Intact
Cells
(A) EGFP-PITP-transfected COS-7 cells were incubated with BODIPY-PC or BODIPY-PI for 15 min at 37C, and, in each case, they were
stimulated with 35 ng/ml EGF (15 min at 37C) and fixed with 4% paraformaldehyde. FRET results in the shortening of the EGFP (donor)
fluorescence lifetime, which is measured by two parameters, the phase shift (p) and relative modulation depth (m). The average lifetime ()
([p 	 m]/2) of EGFP-PITP (donor) in cells that are only incubated with BODIPY-PC and BODIPY-PI (acceptors) does not vary significantly.
In the presence of EGF, there is a significant decrease in the lifetime of EGFP-PITP at the plasma membrane (at 95% confidence interval
p  0.0001, n 
 10). The EGFP lifetime pseudocolor scale is from 1.5 ns (red) to 2.1 ns (dark blue). FRET efficiency is calculated as E 

1  da/d, where da is the lifetime map of the donor in the presence of the acceptor, and d is the average lifetime of the donor in
the absence of the acceptor. The FRET efficiency maps indicate that, at localized donor lifetimes of 1.6 ns, the percent FRET efficiencies
increase to 30%. The efficiency scale is from 0% (dark blue) to 40% (dark red).
(B) Quantification of localized EGFP lifetimes at the plasma membrane and the cytoplasm. An asterisk indicates significant reduction in EGFP
lifetimes after EGF stimulation. A region of interest containing approximately 50 pixels was used to obtain a localized average lifetime value.
The calculated EGFP lifetimes of the individual pixels were averaged (SD).
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Figure 2. FRET Detected at the Golgi, Plasma Membrane, and Cytoplasm between EGFP-PITP and BODIPY-PC or -PI in EGF-Stimulated
Cells
(A) COS-7 cells were transfected with EGFP-PITP and were treated as described in the legend to Figure 1A. The average lifetime of EGFP-
PITP in cells that are incubated only with BODIPY lipids decreases at the Golgi and the plasma membrane. Upon stimulation, there is a
further reduction in the lifetime of EGFP-PITP in both membrane compartments. In the cytoplasm, a reduction in lifetime is only observed
following stimulation with EGF. The FRET efficiency maps indicate that, at localized donor lifetimes of 1.5 ns, the percent FRET efficiencies
increase to 40%. The EGFP lifetime pseudocolor scale is from 1.5 ns (red) to 2.1 ns (dark blue), and the efficiency scale is 0% (dark blue) to
40% (dark red).
(B) Quantification of localized EGFP lifetimes. An asterisk indicates significant reduction in EGFP lifetimes after EGF stimulation (p  0.001,
n 
 6). See the legend to Figure 1B for details.
is able to mediate PC and PI transfer, but at a reduced to wild-type PITP, it also localizes to the Golgi but is
excluded from the nucleus (Figure S1). A modest de-capacity [15]. By using confocal microscopy, we find
that PITP5 is found in the cytoplasm, and, in contrast crease in the EGFP lifetime from 2.00 ns to 1.80 ns at
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the plasma membrane with both BODIPY-PI and -PC shift is observed. As the number of pixels with lower
EGFP lifetimes increases, the shift becomes more prom-suggests FRET in unstimulated cells (Figure S2), and
this is clearly observed in the accumulated data (Figure inent; this is observed with PITP5 and PITP. No shift
in the two-dimensional histogram was observed for the3). A further decrease to 1.70 ns (BODIPY-PC) or 1.50
ns (BODIPY-PI) is observed upon EGF stimulation at transfer-deficient PITPS164E mutant.
The cumulative FRET efficiencies at each pixel, mea-the plasma membrane. In addition, in the cytoplasm, a
decrease is observed with both BODIPY-PI (1.90 ns to sured in all experiments, is shown in Figure 3B, which
shows the number of pixel counts versus FRET effi-1.70 ns) and BODIPY-PC (1.98 ns to 1.70 ns) (Figure S2).
These data corroborate the higher affinity of PITP5 ciency. Again, the shift in the histogram curves shows
the increase in FRET efficiency resulting from an in-for membranes [15–18]. A further reduction in the EGFP
lifetime, seen with EGF, suggests additional conforma- crease in the interaction between the donor and ac-
ceptor fluorophores. These data confirm that FRET istional changes that may bring the lipid into closer prox-
imity to the PITP5 molecule. only seen between EGFP-PITP and BODIPY-PC or
BODIPY-PI when activated by EGF. FRET is also de-If FRET detected between EGFP and BODIPY-PC and
BODIPY-PI was dependent on PITP being able to tected between both EGFP-PITP5 and EGFP-PITP
and BODIPY-PC and BODIPY-PI, but this is observedtransfer PC and PI, then no FRET would be observed
between these lipids and a PITP mutant lacking PC/ in unstimulated cells and is further enhanced upon EGF
stimulation. It is noted that, with EGFP-PITP andPI transfer activity. Rat PITP can be phosphorylated
by protein kinase C at Serine166, and mutation of this BODIPY-PI, in unstimulated cells, there are approxi-
mately 4000 pixels with a higher percent FRET effi-residue to aspartate abolishes both PI and PC transfer
[12]. The analogous residue in human PITP was mu- ciency. Since the data are averages of 21 cells, this
most likely represents the uneven distribution of FRETtated to glutamate (PITPS164E) and was shown to be
inactive for PI transfer as well as reconstitution of PLC efficiency within the cell population studied. However,
upon stimulation with EGF, there is a further increasesignaling in permeabilized HL60 cells (data not shown).
EGFP-PITPS164E showed a similar pattern of localiza- in FRET efficiency. Furthermore, FRET is not detected
between EGFP-PITPS164E and BODIPY-PC ortion to wild-type PITP (Figure S1). FRET between
EGFP-PITPS164E and BODIPY lipids was analyzed, BODIPY-PI with or without EGF.
To further test the hypothesis that EGF receptor acti-and the EGFP lifetimes and FRET efficiencies remained
unchanged before and after EGF stimulation (Figures 3 vation reduces the mobility of PITP by recruiting it to
the plasma membrane, and the hypothesis that EGFP-and S3). These data emphasize that FRET between
PITP and its cargo lipids occurs following EGF addition PITP5 and EGFP-PITP are retained at the mem-
brane, the diffusion coefficients and mobile fractions ofand is dependent on transfer activity.
When COS-7 cells were analyzed for FRET between these proteins were determined by FRAP. EGFP-PITP-,
EGFP-PITP5- and EGFP-PITP-transfected cells wereEGFP-PITP and BODIPY-PC or BODIPY-PI (Figure 2A),
the EGFP lifetime in both the Golgi and plasma mem- bleached either at the cytoplasm, plasma membrane, or
Golgi membranes as appropriate (Table S1). Followingbrane compartment decreased without any change in
the cytoplasm. In the image in Figure 2A, FRET in the stimulation with EGF, the mobile fraction of EGFP-PITP
at the plasma membrane decreases from 91% to 68%,Golgi region is not visually evident due to the limitations
of the pseudocolor scale, but it is obvious from the indicating a reduction in the mobility of the PITP pro-
teins at the membrane. No such change was observedEGFP lifetimes shown in Figure 2B. FRET is not detected
between EGFP-PITP and BODIPY-PE, confirming the with the mobile fraction of EGFP-PITP5 upon EGF
stimulation since its mobility is already restricted (73%).specificity of these interactions (data not shown). Fol-
lowing EGF stimulation, there is a further reduction in Cytoplasmic mobile fractions remain constant for both
proteins. The diffusion coefficient of EGFP-PITP5 atthe EGFP lifetime in the presence of BODIPY-PC or
BODIPY-PI (Figure 2B) at the Golgi, plasma membrane, the plasma membrane (0.09) is significantly lower than
that for PITP (0.25), indicating an increase in membraneand cytoplasm. At the Golgi, the reduction in lifetime
corresponds to an increase to 40% in FRET efficiency. association. The diffusion coefficients of EGFP-PITP
and EGFP-PITP5 are similar at the Golgi, demonstra-The cumulative data for all experiments are present
in Figure 3, illustrating the variation in lifetime popula- ting that they are confined to this compartment. How-
ever, the mobile fraction of EGFP-PITP5 at the Golgi istions and cumulative FRET efficiencies. Figure 3A shows
the two-dimensional histograms that represent three in- significantly higher than that of EGFP-PITP, indicating
higher mobility.dependent experiments (seven cells per experiment).
These are histograms of the cumulative lifetimes of all Ligand binding to the EGF receptor initiates both the
activation of signal transduction pathways and traffick-pixels for the entire cell recorded for EGFP-PITP iso-
forms (blue), in the presence of BODIPY-PC or BODIPY- ing events that relocalize the receptor from the cell sur-
face to intracellular compartments [3]. Receptor traffick-PI (green without EGF and red with EGF). The figure
shows the lifetimes measured by both parameters, ing and signaling are functionally intertwined, and PITP
proteins have been implicated in both processes [19].phase and modulation, where a concomitant decrease
in both indicates a reduction in EGFP lifetime due to EGF receptors participate in the activation of the Ras/
MAP kinase cascade and the phospholipase C-medi-FRET (represented by the diagonal shift toward zero).
Since these histograms take into account the average ated hydrolysis of PI(4,5)P2 [3]. To investigate the contri-
bution of these two signaling pathways on the EGF-lifetime of all the pixels, then, in the case of PITP, where
the FRET occurs only at the plasma membrane, a small stimulated proximity of PITP to PI, we used selective
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Table 1. PI-PLC Inhibitor and MAP Kinase Pathway Inhibitors Inhibit EGF-Stimulated Interaction of EGFP-PITP with BODIPY-PI
Inhibitors Function of Inhibitors ns at Plasma Membrane
EGFP-PITP - - 1.98  0.10
PITP 	 BPI 	 EGF - - 1.69  0.10
DMSO (inhibitor solvent) - - 2.03  0.10
PITP 	 BPI 	 EGF U-73122 Inhibitor of PI-PLC 1.80  0.08**
PITP 	 BPI 	 EGF PD98059 Inhibitor of MEK (1/2) 1.95  0.20**
PITP 	 BPI 	 EGF U0126 Inhibitor of MEK (1/2) 1.97  0.17**
PITP 	 BPI 	 EGF SB203580 Inhibitor of p38 (MAPK) 1.64  0.12
COS cells transfected with EGFP-PITP were labeled with fluorescent lipid as described and then incubated with various inhibitors at 37C
for 10 min or 1 hr prior to stimulation with EGF: these inhibitors include PD98059, 10 M for 10 min; U0126, 360 nM for 1 hr; SB203580, 3
M for 1 hr; and U-73122, 5 M for 10 min. To determine that the lifetime change at the plasma membrane in the presence of the inhibitors
is significantly different than that which takes place without inhibitors, an unpaired t test with Welch corrections was performed at a 95%
confidence interval (p  0.0001, n 
 6) (indicated by a double asterisk). A region of interest containing approximately 50 pixels from 6 separate
cells was analyzed to obtain a localized average lifetime value for each condition. U-73122 partially inhibits the interaction of EGFP-PITP
with BODIPY-PI (BPI), whereas the inhibitors PD98059 and U0126, which inhibit the same MAP kinase pathway, almost completely prevent
the interaction. SB203580 does not inhibit the interaction, indicating that the MAP kinase (ERK1/2) pathway rather than the p38 MAP kinase
pathway has an effect on the interaction of EGFP-PITP with BODIPY-PI.
inhibitors of these two pathways. U-73122, an inhibitor result in measuring nonspecific interactions via the con-
ventional intensity methods, but not via lifetime mea-of PLC, partially prevented the decrease in the lifetime
of EGFP induced by EGF (Table 1). (EGF-stimulated PLC surements [22]. In our study, we have measured the
effect of changes in the donor lifetime upon FRET be-activity was only partially blocked [data not shown]).
PD98059 and U0126 selectively block the p42/p44 MAP tween PITPs and the acceptor lipids, PI and PC, at the
plasma membrane upon stimulation with EGF. It shouldkinase cascade in cell-based assays by preventing the
activation of MAP kinase [20]. Both inhibitors reversed be emphasized that that the variations of lifetime do not
occur with the addition of unlabeled lipids or BODIPY-the decrease in the lifetime of EGFP measured in the
presence of EGF (Table 1) without any inhibition of PLC PE (data not shown), or with a PITP mutant that cannot
mediate lipid transfer.activity (data not shown). To determine the selectivity of
the different MAP kinase pathways, we used SB203580, These investigations demonstrate that in vivo PITP
protein dynamics are regulated in response to EGF andwhich inhibits the stress-activated p38 MAP kinase [20].
This inhibitor was without effect. are downstream to both the Ras/MAP kinase cascade
and PLC1. Because PITP and PITP show FRET with
the lipids at the plasma membrane, this provides anConclusions
The detection of resonance energy transfer between a indirect measure of the specific membrane association
of PITP upon EGF stimulation. The earliest time the regu-donor and acceptor pair by measuring variations in the
lifetime of the donor allows us to monitor localized pro- lation of PITP by EGF was observed was at 15 min
poststimulation (data not shown), while PLC was acti-tein-lipid interactions that are concentration and optical
path length independent [6–8, 21]. These two factors vated within minutes. This information, together with
the observation that inhibitors of the Ras/MAP kinasecannot be easily accounted for when FRET is measured
by conventional intensity methods [7]. The distribution pathway were able to inhibit the recruitment of PITP
to the plasma membrane, suggests that the driving forceof the acceptor lipids could vary, and when measuring
protein-lipid interactions at the membrane, this could that leads to the recruitment of PITP to the membrane
is not just depletion of PI. For PITP/ to exchange itsresult in nonspecific FRET, when it is monitored via
conventional intensity methods. If this distribution ex- bound lipid, PITP has to dock to the membrane, insert
itself in the membrane, and off-load its cargo lipid, andceeds 0.5% (acceptor lipid/mol total lipid), this may also
Figure 3. Analysis of FRET by Two-Dimensional Cumulative Histograms and Quantification of FRET Efficiency
(A) The cumulative lifetimes of EGFP-PITP from three experiments (seven cells per experiment) were plotted on two-dimensional histograms,
showing both the phase (p) and modulation (m) measurements for all recorded pixels. EGFP-PITP-transfected cells (donor alone) are shown
in blue. In the presence of both donor (EGFP-PITP) and acceptor (BODIPY-PC or -PI), phase (p) and modulation (m) are shown in green for
unstimulated cells and red for EGF-stimulated cells. A concomitant decrease in both, and the resultant diagonal shift, indicates a reduction
in the EGFP lifetime due to FRET. Since these histograms take into account the average lifetime of all the pixels, then, in the case of PITP,
where the FRET occurs only at the plasma membrane, a small shift is observed. As the number of pixels with lower EGFP lifetimes increases,
the shift becomes more prominent; this is observed with PITP5 and PITP. No shift in the two-dimensional histogram was observed for
the transfer-deficient PITP164E mutant.
(B) Cumulative histograms of all the FRET efficiencies at each pixel, measured in 30 cells (10 cells per experiment), are represented as the
number of pixel counts versus FRET efficiency. FRET is enhanced when PITP mobility is reduced at the membrane upon EGF stimulation,
and this is indicated by a shift in the two-dimensional histograms and FRET efficiency histograms. FRET is only seen between EGFP-PITP
and the BODIPY lipids when stimulated with EGF (see shift in green curve). FRET is detected between EGFP-PITP5 and BODIPY lipids,
but this is observed in unstimulated cells and is further enhanced upon EGF stimulation (red curve). FRET is also detected between EGFP-
PITP and BODIPY lipids, but this is observed in unstimulated cells and is further enhanced upon EGF stimulation (yellow curve). No significant
FRET is seen with EGFP alone (blue curve) or with the mutant PITPS164E (black curve).
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Wirtz, K.W.A., and Snoek, G.T. (1996). Fluorescently labeledfinally released from the membrane [23]. The observa-
phosphatidylinositol transfer protein isoforms ( and ), mi-tions that both EGFP-PITP5 and EGFP-PITP un-
croinjected into fetal bovine heart endothelial cells, are targeted
dergo increased FRET upon stimulation despite being to distinct intracellular sites. Exp. Cell Res. 227, 33–39.
associated with membranes suggests that stimulation 11. Segui, B., Allen-Baume, V., and Cockcroft, S. (2002). Phosphati-
of the cells allows for a physical change that could po- dylinositol transfer protein-beta displays minimal sphingomye-
lin transfer activity and is not required for biosynthesis andtentially be the membrane insertion of hydrophobic resi-
trafficking of sphingomyelin. Biochem. J. 366, 23–34.dues on the PITP molecule. Membrane insertion may be
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fer protein complexed with phosphatidylcholine. J. Biol. Chem.PITP recruitment observed in these studies [27].
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